Therapeutic misalignment averted by clonal evolutionary evidence: molecular confirmation of hepatic metastasis in SMARCA4-deficient non-small cell lung cancer initially misdiagnosed as resectable cholangiocarcinoma
ObjectivesSMARCA4-deficient non-small cell lung cancer (SMARCA4-dNSCLC) exhibits significant histomorphological diversity and intertumoral heterogeneity. Immunophenotypically, it often lacks lineage-specific markers, making diagnosis challenging, especially in cases of hepatic metastasis. Currently,...
Guardat en:
| Autors principals: | , , , |
|---|---|
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Frontiers Media S.A.
2026-03-01
|
| Col·lecció: | Frontiers in Oncology |
| Matèries: | |
| Accés en línia: | https://www.frontiersin.org/articles/10.3389/fonc.2026.1743908/full |
| Etiquetes: |
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|
